Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-lactoglobulin-like protein refers to a member of the lipocalin family, closely related to the well-known beta-lactoglobulin found in ruminant (e.g., cow and sheep) milk, which functions as the main whey protein and acts as a carrier for small hydrophobic molecules. The human genome encodes a beta-lactoglobulin-like gene (ENSG00000236543, LOC102723971), but this gene is considered a pseudogene in humans and does not produce a functional protein. In other mammals, beta-lactoglobulin is a major milk protein with well-documented ligand-binding and carrier activities, possible roles in neonatal nutrition, and is a recognized allergen. Its biological function in humans is not established, and it is not a recognized therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-lactoglobulin-like protein.